Reference : Comment je traite ... le myelome multiple refractaire par thalidomide

	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Hematology
	To cite this reference:	http://hdl.handle.net/2268/10160

Title :	Comment je traite ... le myelome multiple refractaire par thalidomide
Language :	French
Alternative title :	[en] How I Treat... Refractory Multiple Myeloma with Thalidomide
Author, co-author :	Scerbo, F. [> > > >]
	Matus, G. [> > > >]
	Sautois, Brieuc [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
	Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale]
Publication date :	Nov-2000
Journal title :	Revue Médicale de Liège
Volume :	55
Issue/season :	11
Pages :	970-3
ISSN :	0370-629X
Abstract :	[en] Despite the use of high-dose chemotherapy with autologous hematopoietic stem cell transplantation, multiple myeloma remains largely uncurable. Indeed complete remission rate is about 50% and median survival reaches 5 years without plateau. Recently thalidomide has been identified as a promising agent. We report the clinical story of 2 patients with refractory myeloma that we treated successfully with thalidomide.
Permalink :	http://hdl.handle.net/2268/10160

There is no file associated with this reference.

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5